Viruses have been classified as non-living because they require a cellular host to support their replicative processes. Empirical investigations have significantly advanced our understanding of the many strategies employed by viruses to usurp and divert host regulatory and metabolic processes to drive the synthesis and release of infectious particles. The recent emergence of SARS-CoV-2 has permitted us to evaluate and discuss a potentially novel classification of viruses as living entities. The ability of SARS CoV-2 to engender comprehensive regulatory control of integrative cellular processes is strongly suggestive of an inherently dynamic informational registry that is programmatically encoded by linear ssRNA sequences responding to distinct evolutionary constraints. Responses to positive evolutionary constraints have resulted in a single-stranded RNA viral genome that occupies a threedimensional space defined by conserved base-paring resulting from a complex pattern of both secondary and tertiary structures. Additionally, regulatory control of virus-mediated infectious processes relies on extensive protein-protein interactions that drive conformational matching and shape recognition events to provide a functional link between complementary viral and host nucleic acid and protein domains. We also recognize that the seamless integration of complex replicative processes is highly dependent on the precise temporal matching of complementary nucleotide sequences and their corresponding structural and non-structural viral proteins. Interestingly, the deployment of concerted transcriptional and translational activities within targeted cellular domains may be modeled by artificial intelligence (AI) strategies that are inherently fluid, self-correcting, and adaptive at accommodating temporal changes in host defense mechanisms. An in-depth understanding of multiple self-correcting AIassociated viral processes will most certainly lead to novel therapeutic development platforms, notably the design of efficacious neuropharmacological agents to treat chronic CNS syndromes associated with long-COVID. In summary, it appears that viruses, notably SARS-CoV-2, are very much alive due to acquired genetic advantages that are intimately entrained to existential host processes via evolutionarily constrained AI-associated learning paradigms.

Center for Cognitive and Molecular Neuroscience 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Koshland D.E. Jr Special essay. The seven pillars of life. Science. 2002;295(5563):2215–2216. doi: 10.1126/science.1068489. PubMed DOI

Huston N.C., Wan H., Strine M.S., de Cesaris Araujo Tavares R., Wilen C.B., Pyle A.M. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. . Mol. Cell. 2021;81(3):584–598.e5. doi: 10.1016/j.molcel.2020.12.041. PubMed DOI PMC

de Haan C.A., Rottier P.J. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005;64:165–230. doi: 10.1016/S0065-3527(05)64006-7. PubMed DOI PMC

Kim D., Lee J.Y., Yang J.S., Kim J.W., Kim V.N., Chang H. The Architecture of SARS-CoV-2 transcriptome. Cell. 2020;181(4):914–921.e10. doi: 10.1016/j.cell.2020.04.011. PubMed DOI PMC

Wong N.A., Saier M.H., Jr The SARS-coronavirus infection cycle: A survey of viral membrane proteins, their functional interactions and pathogenesis. Int. J. Mol. Sci. 2021;22(3):1308. doi: 10.3390/ijms22031308. PubMed DOI PMC

Stefano G.B. In: CRC Handbook of comparative opioid and related neuropeptide mechanisms. Stefano G.B., editor. Vol. 2. Boca Raton: CRC Press Inc.; 1986. Conformational matching: A possible evolutionary force in the evolvement of signal systems. pp. 271–277.

Stefano G.B. The evolvement of signal systems: Conformational matching a determining force stabilizing families of signal molecules. Comp. Biochem. Physiol. C. Comp. Pharmacol. Toxicol. 1988;90(2):287–294. doi: 10.1016/0742-8413(88)90001-1. PubMed DOI

Nasir A., Romero-Severson E., Claverie J.M. Investigating the concept and origin of viruses. Trends Microbiol. 2020;28(12):959–967. doi: 10.1016/j.tim.2020.08.003. PubMed DOI PMC

Stefano G.B., Kream R.M. Mitochondrial DNA heteroplasmy as an informational reservoir dynamically linked to metabolic and immunological processes associated with COVID-19 neurological disorders. Cell. Mol. Neurobiol. 2021;42(1):99–107. doi: 10.1007/s10571-021-01117-z. PubMed DOI PMC

Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O’Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., Tummino T.A., Hüttenhain R., Kaake R.M., Richards A.L., Tutuncuoglu B., Foussard H., Batra J., Haas K., Modak M., Kim M., Haas P., Polacco B.J., Braberg H., Fabius J.M., Eckhardt M., Soucheray M., Bennett M.J., Cakir M., McGregor M.J., Li Q., Meyer B., Roesch F., Vallet T., Mac Kain A., Miorin L., Moreno E., Naing Z.Z.C., Zhou Y., Peng S., Shi Y., Zhang Z., Shen W., Kirby I.T., Melnyk J.E., Chorba J.S., Lou K., Dai S.A., Barrio-Hernandez I., Memon D., Hernandez-Armenta C., Lyu J., Mathy C.J.P., Perica T., Pilla K.B., Ganesan S.J., Saltzberg D.J., Rakesh R., Liu X., Rosenthal S.B., Calviello L., Venkataramanan S., Liboy-Lugo J., Lin Y., Huang X.P., Liu Y., Wankowicz S.A., Bohn M., Safari M., Ugur F.S., Koh C., Savar N.S., Tran Q.D., Shengjuler D., Fletcher S.J., O’Neal M.C., Cai Y., Chang J.C.J., Broadhurst D.J., Klippsten S., Sharp P.P., Wenzell N.A., Kuzuoglu-Ozturk D., Wang H.Y., Trenker R., Young J.M., Cavero D.A., Hiatt J., Roth T.L., Rathore U., Subramanian A., Noack J., Hubert M., Stroud R.M., Frankel A.D., Rosenberg O.S., Verba K.A., Agard D.A., Ott M., Emerman M., Jura N., von Zastrow M., Verdin E., Ashworth A., Schwartz O., d’Enfert C., Mukherjee S., Jacobson M., Malik H.S., Fujimori D.G., Ideker T., Craik C.S., Floor S.N., Fraser J.S., Gross J.D., Sali A., Roth B.L., Ruggero D., Taunton J., Kortemme T., Beltrao P., Vignuzzi M., García-Sastre A., Shokat K.M., Shoichet B.K., Krogan N.J.A.A. SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–468. doi: 10.1038/s41586-020-2286-9. PubMed DOI PMC

Malone B., Urakova N., Snijder E.J., Campbell E.A. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 2021 PubMed PMC

Kelly J.A., Olson A.N., Neupane K., Munshi S., San Emeterio J., Pollack L., Woodside M.T., Dinman J.D. Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2). J. Biol. Chem. 2020;295(31):10741–10748. doi: 10.1074/jbc.AC120.013449. PubMed DOI PMC

Fehr A.R., Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol. Biol. 2015;1282:1–23. doi: 10.1007/978-1-4939-2438-7_1. PubMed DOI PMC

Faheem; Kumar, B.K.; Sekhar, K.V.G.C.; Kunjiappan, S.; Jamalis, J.; Balaña-Fouce, R.; Tekwani, B.L.; Sankaranarayanan, M. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorg. Chem. 2020;104:104269. doi: 10.1016/j.bioorg.2020.104269. PubMed DOI PMC

Emmert-Streib F., Yli-Harja O., Dehmer M. Artificial intelligence: A clarification of misconceptions, myths and desired status. Front Artif Intell. 2020;3:524339. doi: 10.3389/frai.2020.524339. PubMed DOI PMC

Krupovic M., Dolja V.V., Koonin E.V. Origin of viruses: Primordial replicators recruiting capsids from hosts. Nat. Rev. Microbiol. 2019;17(7):449–458. doi: 10.1038/s41579-019-0205-6. PubMed DOI

Int. International Committee on Taxonomy of Viruses Executive Committee. 2020 The new scope of virus taxonomy: Partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol. 2020 PubMed PMC

Ho J.S.Y., Zhu Z., Marazzi I. Unconventional viral gene expression mechanisms as therapeutic targets. Nature. 2021;593(7859):362–371. doi: 10.1038/s41586-021-03511-5. PubMed DOI

Primordial Biochemicals Within Coacervate-Like Droplets and the Origins of Life

Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior

Independent and sensory human mitochondrial functions reflecting symbiotic evolution

HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae

Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms